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Background: Out of pocket expenditure (OOPE) on healthcare is related to the burden of illness and the number
of chronic conditions a patient experiences, but the relationship of these costs to particular conditions and groups
of conditions is less studied. This study examines the effect on OOPE of various morbidity groupings, and explores
the factors associated with a ‘heavy financial burden of OOPE’ defined by an expenditure of over 10% of
equivalised household income on healthcare.
Methods: Data were collected from 4,574 senior Australians using a stratified sampling procedure by age, rurality
and state of residence. Natural clusters of chronic conditions were identified using cluster analysis and clinically
relevant clusters based on expert opinion. We undertook logistic regression to model the probability of incurring
OOPE, and a heavy financial burden; linear regression to explore the significant factors of OOPE; and two-part
models to estimate the marginal effect of factors on OOPE.
Results: The mean OOPE in the previous three months was AU$353; and 14% of respondents experienced a heavy
financial burden. Medication and medical service expenses were the major costs. Those who experienced cancer,
high blood pressure, diabetes or depression were likely to report higher OOPE. Patients with cancer or diabetes were
more likely than others to face a heavy burden of OOPE relative to income. Total number of conditions and some
specific conditions predict OOPE but neither the clusters nor pairs of conditions were good predictors of OOPE.
Conclusions: Total number of conditions and some specific conditions predict both OOPE and heavy financial burden
but particular comorbid groupings are not useful in predicting OOPE. Low-income patients pay a higher proportion of
income than the well-off as OOPE for healthcare. Interventions targeting those who are likely to face severe financial
burdens due to their health could address some of these differences.
Keywords: Costs, Financial stress, Long term conditions, Multimorbidity, Comorbidity, Disease clusterBackground
Chronic conditions are by definition long-term, and
patients with such conditions often require continuing
care. Responding to the care demands of people with
chronic conditions is a challenge in most countries in
the world [1]. Health services may impose a regressive
cost burden on households [2]. Even in countries with
universal healthcare coverage, patients including those
with chronic conditions can still incur substantial and* Correspondence: mofizul.islam@anu.edu.au
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unless otherwise stated.increasing amounts of out-of-pocket expenditure (OOPE)
[3-5]. In Australia, for example, overall average OOPE
increased by around 30% between 2007 and 2010-11 [6],
and OOPE accounts for almost a quarter of total
healthcare costs [5]. High levels of OOPE on healthcare
may leave insufficient income for other necessities, and
may also impede access to healthcare, affecting health
status and quality of life [7]. OOPE is often felt most
severely if it becomes excessive relative to income,
particularly for elderly people with multiple chronic
conditions who require regular and on-going engagement
with the health system for the management of their health
conditions [8,9].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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OOPE is likely to be influenced by a range of factors
including, but not limited to, the type, total number and
severity of diseases and patients’ socio-economic status
[7,12-14]. The level of this spending also varies by age and
insurance coverage, among other characteristics [7]. In the
literature the most prominent, among these factors, has
been the total number of chronic conditions [7,15-17] and
OOPE has always been found to be directly associated to
this total number. McRae et al found that not only was
the total number a significant factor but that people
with multiple chronic conditions tended to be from
lower income groups. In addition, they found that each
additional chronic condition added an estimated 46% to
the likelihood of a person facing a severe financial burden
due to health costs [17].
A patient’s OOPE is likely to be shaped not only by the
total number of chronic conditions, but also by the type
and patterns of comorbid chronic conditions, and the main
focus of this study is to address this relationship. While
there has been considerable study of particular comorbid
combinations, including study of costs [18,19] and OOPE
[20,21], these are targeted studies and there has been little
if any work which looks at the relative impacts across a
range of comorbidities. There is now a literature assessing
the common natural clusters of chronic conditions that
tend to co-occur [22-27]. A previous study examined the
effect of some common disease clusters – with clusters
defined mainly based on prevalent conditions – on OOPE
[16]. However, there are many possible combinations of
conditions, hence many ways of addressing multimorbid
structures such as simple counts of chronic conditions,
prevalent pairs or triplets, natural clusters identified using
similarity measures (not with prevalence measures only),
clinically relevant clusters. It is important to examine the
effect of all these structures along with the effect of individ-
ual chronic conditions on OOPE to avert a fragmented and
incomplete understanding of the role of comorbidity
patterns. However, to our knowledge no previous study has
examined the relative impact of all these combinations on
the level of OOPE together in one paper. Neither has it
been assessed whether any of these groupings or conditions
was likely to account for a burdensome level of OOPE. The
aim of this study is to examine the roles of specific chronic
conditions and of comorbid structures on the level
of OOPE, using a range of measures and clustering
arrangements, and to explore the significant variables
associated with a high burden of healthcare costs reflected
by over 10% of income being expended on OOPE.
Methods
Study setting and health care delivery system
Australia has a publicly funded universal health care
scheme known as Medicare. Residents are entitled tosubsidised treatment from private medical practitioners,
and for some services from nursing and allied health
professionals. Australians can obtain free treatment in
public hospitals, and private health insurance is available for
patients preferring private services in hospital. Under the
broad umbrella of Medicare there is also a Pharmaceutical
Benefits Scheme (PBS), which provides subsidised pre-
scription drugs. An estimated 80% of all prescription
medicines dispensed in Australia receive subsidy via
the PBS [28]. There is a concessional and a general
co-payment rate, and also a safety net so that when a
patient reaches the threshold their PBS patient contribution
is reduced or removed [29].
Participants
A validated questionnaire was mailed to a representative
cross-section of the membership (n = 10,000) of National
Seniors Australia during mid-2009. National Seniors
Australia is a nation-wide organisation with 285,000 mem-
bers aged over 50 years. A stratified sampling procedure
by age, rurality and state of residence was applied.
Respondents were asked ‘Has a doctor ever told you
that you had any of the following illnesses?’ This was
followed by the list of 11 conditions and allowed for
other conditions to be reported under ‘other chronic
condition’. While information was collected on all
conditions that lasted more than six months, the
listed conditions were cancer, heart disease, high
blood pressure (HBP), diabetes, arthritis, osteoporosis,
asthma, bronchitis, Parkinson’s disease, depression and
anxiety. As Parkinson’s disease had a very low prevalence
(<2.0%), it was excluded from clustering.
The data collection method is described in detail in
McRae et al. [17]. The survey and study were approved
by the Australian National University Human Research
Ethics Committee (no. 2009/309).
Out-of-pocket expenditure
OOPE was defined as the total amount of own money
respondents spent on both medical expenses and
nonmedical expenses (e.g. transport, home care) related
to care processes pertinent to healthcare. In Australia,
home care includes domestic assistance, personal care and
respite care and depending on individual needs may
include services such as meals, transport, shopping and
home maintenance [30]. Respondents were asked to
report their personal OOPE during the previous three
months under the main categories of health-related
services, including medication, medical services, transport,
medical equipment, home care and other expenses. Health
insurance premiums were not included, because the focus
of this study was to measure the financial burden that is
directly related to out-of-pocket costs for medical care.
Respondents reporting ‘do not know’ to any category
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extreme expenses such as those for housing modifications
(one observation over $20,000) and very expensive hearing
aids had the potential to significantly influence estimates,
observations with quarterly costs of $5,000 or over
were excluded when estimating total costs (removing
26 observations or ~1% of observations reporting
total expenditure).
Comorbid groups and prevalent pairs
Cluster analysis was used to establish the “natural
groups” of chronic conditions – specifically, a partitional
cluster analysis was undertaken using k-medoids and
Yule’s Q similarity measure [27]. For modelling purposes,
participants with none of the ten conditions were classi-
fied as the reference cluster.
From a disease management perspective in clinical
practice [31] our clinical and content expert identified a
set of clusters that, unlike partitional clusters, are not
mutually exclusive. Thus a participant may belong to
more than one clinically suggested cluster depending on
the type of chronic conditions. Here again participants
with no diseases become the reference group.
As an alternative means of addressing co-morbidity,
following Schoenberg et al. [16]’s approach we created a
categorical variable labeled ‘multiple morbidity’. Among
those individuals with only one chronic illness HBP and
arthritis were the most frequently occurring, so we
categorised individuals with one condition into three
sub-groups: those with HBP only, those with arthritis
only, and those with only one condition but not arthritis
or HBP. Participants with only two conditions were
divided into five sub-groups: HBP + arthritis, HBP +
diabetes, HBP + heart disease, arthritis + asthma, all
other combinations of only two conditions. We constructed
three sub-groups with the participants with only three con-
ditions: HBP + arthritis + cancer, HBP + arthritis + diabetes,
and all other combinations of three conditions. Although
we could have used more sub-groups with two or three
condition combinations, we did not go any further as the
prevalence of such combinations became increasingly very
small. This categorical variable ‘multiple morbidity’
contained all the above groups together with a category
for those with four conditions, and a category for those
with more than four conditions. The group with HBP only
was selected as the reference group as it was the
most common condition that tends to be associated with
other conditions.
For many conditions the cost faced by a single patient
with two conditions may be different from the sum of hav-
ing the same two conditions separately [32], a phenomenon
known as interaction, which then modifies the outcomes.
The modified effect could be greater (positive interaction,
synergism) or less (negative interaction, antagonism)than simple addition of the two effects [33]. To see
whether there is any interaction due to having two
particular conditions we used the most prevalent pairs
(because there are 45 combinations of ten conditions,
many of which are rare, we use conditions pairs with
observed prevalence of ≥ 5%) along with the individual
conditions in the regression models to examine the effect
modification of these combinations.
Other variables
A number of covariates were considered during analyses
selected from analytical domains that previous studies
have shown to be associated with OOPE [17]. These
included socio-demographic variables such as age, sex,
income, physical and mental health status reflected by
SF-12 [34], region and number of ‘other chronic condi-
tions’. The SF-12 is a widely used 12-item measure of
health-related quality of life. Items are summarized into two
weighted scales representing perceived impairment in role
functioning associated with physical and mental health
problems, with lower scores indicating greater impairment
[34]. We included SF-12 measures to address participants’
physical and mental health status – as a proxy for disease
severity. Income was converted to ‘household equivalent
income’ using the modified Organisation for Economic
Co-operation and Development (OECD) equivalence scales
which apply a scale of 1 to the first adult in a household,
0.5 to the second and later adults, and 0.3 to children [35].
Financial burden
As well as analysing OOPE, it is important to understand
which groups of people face the greatest financial burdens
due to their healthcare costs. For the purposes of this study,
a heavy financial burden was defined as expending over
10% of equivalised household income on OOPE. Although
this percentage is necessarily somewhat arbitrary, it has
been used by a number of previous studies [3,7,17,36].
Approach to modelling
The distribution of the OOPE variable contains an
abundance of zeros (30% of those who responded)
and a highly skewed distribution of nonzero values.
There are in practice two processes occurring – one
which establishes a requirement to expend any OOPE
on health matters, and second process which establishes
the size of the OOPE conditional on it being non-zero.
One approach to handling this data is to undertake two
sets of regression: firstly a logistic regression exploring the
probability of incurring OOPE, and secondly a linear
regression of how much is spent with the subset who
reported more than zero expenditure, after logarithmic
transformation of that subset. These two regressions are
then interpreted separately.
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jointly using an approach based on a parametric mixture
distribution [37], which addresses both the abundance of
zeros and the skewed distribution of non-zero values in
the same model. Both of these approaches are known as
two-part models, and the latter is also known as two-part
joint regression model [38]. For the joint regression model
we used STATA tpm command [37]. In order to show the
nature of the two distinct processes as well as the overall
process, in this article we used both of these approaches
as shown in Figure 1. This means we report on four
groups of models – (i) whether a respondent has any
OOPE, (ii) the amount of OOPE for those with any
OOPE, (iii) the joint modelling of the two previous models,
and (iv) models based on whether the respondents faced a
heavy cost burden from their conditions.
Models estimated
For each of these four groups (i-iv mentioned above) a
set of five models were estimated: model 1 estimated the
association between the relevant measure of OOPE
and aggregated number of chronic conditions; model
2 estimated the association between OOPE and specific
chronic conditions; model 3 estimated the association
between OOPE and ‘multiple morbidity’; model 4 estimated
the association between OOPE and natural clusters; and
model 5 estimated the association between OOPE and
clinically relevant clusters.
To see the effect modification of one condition on
another we also assessed the effect of prevalent pairs
on both of the dependent variables. However, for the
sake of parsimony we have chosen to report these results
briefly in the text rather than in the tables.
Multicolinearity was assessed using variance inflation
factors (VIF) and not found to be a problem. Models
were compared using Akaike information criterionOO
Dat
OOPE as 
semicontinuous data
Logistic 
regression 
with zero vs 
non-zero 
expenditure 
(Table 5) 
Linear regression 
with non-zero 
expenditure only, 
after logarithmic 
transformation 
(Table 6)
Figure 1 Regression analyses for four groups of models.(AIC) and Bayesian information criterion (BIC). Data
were analysed using STATA (version 12). To make the
coefficients (β) of the models in group-ii regressions easily
interpretable they have been exponentially transformed
and reported as a value B. The interpretation is that a
one unit (e.g. from zero to one) increase of independent
variable would result in (B-1)*100 percentage change
in OOPE.
The Mantel-Haenszel chi-square test for linear trend
(χ2trend) was used to assess whether the proportion of par-
ticipants who spent over 10% of income as OOPE showed
a trend in relation to their level of household income.
Results
Demographic characteristics
A total of 4,574 participants completed the survey; the
response rate was 45.7%, of which 43% were male and
57% female. Participants’ mean age was 69.3 years, 15
participants identified themselves as of Aboriginal or
Torres Strait Islanders descent. More than three quarters
(77%) were born in Australia. Over half of the partici-
pants had post school qualifications. Sixty percent were
completely retired or pensioners. The participants were
similar to the average Australian population of this
age on most of the demographic characteristics except
that the participants were better educated (certificate/
diploma/university degree: 55.8% cf 36.6%), reported
better health (excellent/very good/good: 85.8% cf 68.0%)
and were more likely to have private insurance coverage
than the average Australian in their age range (81%
cf 57%). The sample was also similar to the average
Australian population in terms of estimated preva-
lence of chronic conditions in the similar age group,
except that the sample had higher prevalence of HBP,
history of cancer diagnosis and a lower prevalence of
arthritis [17].PE 
aset
OOPE in a binary 
form: heavy vs normal 
financial burden (Table 
8)
Two-part joint 
regression 
model
(Table 7) 
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Eighty-two percent of participants reported having at least
one chronic condition and over 52% having at least two
chronic conditions. Overall, 27% reported at least three
chronic conditions, 11% have at least four and 3% have at
least five conditions. HBP (43.1%), arthritis (32.2%) and
asthma/hayfever (18.2%) were three most prevalent
conditions (Table 1). Female participants reported a
significantly higher number of conditions than male
participants. Participants suffering from any chronic
conditions had an average of 2.4 comorbid conditions.
Table 2 shows the most frequently co-occurring pairs
of conditions.
The cluster analysis identified four natural groups
depending on combinations of conditions, and we label
the clusters according to the dominant conditions in
each group. For instance, 46% of the participants with
HBP fell in Natural Cluster 3 with the rest in Natural
Cluster 1 (23%), Natural Cluster 2 (16%) and Natural
Cluster 4 (15%), so for the purpose of identifying clusters
participants with HBP were labelled as belonging to
Natural Cluster 3. This group was also the dominant
group for diabetes, and hence we describe Natural Cluster
3 as HBP and diabetes cluster. Clinically derived clusters
are shown in the right half of Table 3.
Out-of-pocket expenditure and significant factors
The mean OOPE on healthcare in the previous three
months was AU$353, with a median expenditure of AU
$150. Fourteen percent of the participants reported a
heavy financial burden, reflected by over 10% of income
being expended on OOPE. Medication and medical
services expenses are the major components of these
costs, but substantial costs also applied for equipment
and other expenses.Table 1 Prevalence of individual conditions, corresponding o
Conditions Weighted
prevalence (%)*
Participants with one
condition only % Mean
High blood pressure 43.1 8.15
Arthritis 32.2 4.48
Asthma/hayfever 18.2 2.03
Cancer 17.9 2.88
Depression 15.3 1.01
Diabetes 12.8 1.27
Heart disease 12.3 1.68
Osteoporosis 9.3 1.11
Bronchitis/Emphysema 3.4 0.11
Stroke 3.2 0.15
Parkinson’s disease 0.60 0.10
Other 25.4 2.54
*Weighted to reflect the age, sex, and State structure of the Australian population.Table 4 provides a summary of the significant effects
in each of the models reported in Tables 5, 6, 7, and 8.
The number of chronic health conditions was a signifi-
cant determinant of all the different financial outcomes
assessed in the modelling. For example, the likelihood of
reported OOPE greater than zero increases by 44% per
additional chronic disease (Table 5). Sub-group analysis
also shows that among the participants who reported any
expenditure the OOPE increases by 20% for an additional
chronic disease (Table 6). Similar and significant associa-
tions were also observed in other two groups of regressions
(Table 7 and Table 8).
Examination of individual conditions reveals that
different subsets of diseases from the set comprising
cancer, HBP, diabetes, depression, heart and asthma
were significant in one or more approaches. Cancer is
the only condition common in all approaches.
The results of Model 3 addressing the combined
multi-morbidity structure show predominantly that the
non-specific combinations of two, three, four and more
diseases are significantly different to the omitted category
of HBP only. The only exception was in the model which
examines the factors correlated with the burden of OOPE,
where the specific combination with HBP, arthritis and
diabetes was also significant (Table 8).
The “natural clusters” were clearly well defined as all
of them were significantly different to the “having no
chronic conditions” reference group under each approach
to modelling, but the groupings were never significantly dif-
ferent one from another. The clinically defined conditions
again were generally associated with having significantly
greater OOPE than having no chronic conditions, while
not significantly different one from another. The two
exceptions were that for the model identifying those who
did and did not have any OOPE the cardiovascular clusterther conditions and total out-of-pocket expenditure
Other conditions and out-of-pocket expenditure
total number of other conditions (±SE) Total OOPE in AUD (±SE)
2.83 (0.03) 459 (53.7)
3.07 (0.04) 461 (31.1)
3.28 (0.06) 547 (56.6)
3.06 (0.05) 702 (82.0)
3.49 (0.06) 624 (59.6)
3.24 (0.06) 503 (53.7)
3.28 (0.06) 543 (52.2)
3.38 (0.07) 465 (68.6)
4.07 (0.12) 436 (76.3)
3.82 (0.12) 453 (68.1)
3.61 (0.26) 504 (160.0)
2.92 (0.05) 544 (43.4)
Table 2 Most frequently co-occurring pairs of conditions
Frequently co-occurring pairs Weighted Prevalence (%)
HBP and Arthritis 18.05
HBP and Cancer 8.77
Arthritis and asthma/hayfever 8.02
HBP and Heart disease 8.33
HBP and Asthma/hayfever 7.61
Arthritis and Cancer 6.97
HBP and Diabetes 7.98
Arthritis and Depression 6.71
HBP and Depression 6.65
Arthritis and Heart disease 6.21
Arthritis and Osteoporosis 5.62
HBP: High blood pressure.
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joint modelling the cancer group was the only cluster
significantly different to the no condition group, and
was different to most other clusters.
Other factors that were significantly associated with
the OOPE and/or OOPE burden were predominantly
gender, physical and mental health status reflected in the
SF-12 score and income, with rurality being significant
in three groups of regressions (Tables 5, 6 and 7) and
age in two (Table 6 and Table 7). OOPE among those
who reported some expenditure was likely to be higher for
participants who were relatively young, male, had poor
physical and mental health as reflected in the SF-12, had
high income and lived in urban areas.
The probability of heavy financial burden declines
significantly with increasing levels of income (χ2trend = 4.87,
p = 0.03). None of the prevalent pairs tested were significant
in the linear regressions, suggesting the absence of effect
modification on OOPE by one disease on another, at least
in the common combinations.
For all approaches, the AIC/BIC measures are similar
across the 5 equations, but are lowest for the first equation
suggesting that the equation based only on number of
conditions provides as good a measure of fit as any
of the equations which include information on specific
conditions after accommodating parsimony.Table 3 Natural clusters from partitional cluster analysis and
Natural cluster (mutually exclusive) Clinica
Natural
Cluster 1
Natural
Cluster 2
Natural
Cluster 3
Natural
Cluster 4
Clinica
Cluster
Asthma Heart HBP Cancer Asthma
Bronchitis Stroke Diabetes Bronch
Arthritis
Osteoporosis
DepressionDiscussion
The examination of clusters and dominant pairs did
not give any clear discrimination between groups of
conditions, except for supporting the conclusion that
some individual conditions do stand out. The ‘multiple
morbidity’ variable, which we developed following the
approach of Schoenberg et al. [16], showed that the
non-specific combinations of two, three, four and more
conditions offer more strongly predictive information than
the combination of specific conditions. Together these
findings suggest that at least in our dataset the total
number of chronic diseases and individual chronic
diseases offer better and more useful information
about OOPE and heavy financial burden than the
clusters, dominant groups or dominant pairs. Clearly,
among those who reported some expenditure OOPE
increases with increasing number of chronic conditions,
and it is significantly higher among those with cancer,
depression, diabetes or HPB than those who did not
have of these diseases.
Total number of diseases is clearly a significant
determinant of OOPE and of the heavy financial burden.
While this is to be expected as more conditions means
more doctor visits and probably to several doctors, more
tests and more medications, the fact that this dominates
over any particular disease combinations is important.
While there are not necessarily easy solutions to the
pressures of multi-morbidity, health professionals dealing
with multi-morbid patients need to be aware of these
potential financial pressures in proposing treatments, and
policy makers need to be aware of the growing pressures
on both personal and government budgets.
Among the individual conditions, cancer in particular
led to significant OOPE under all constructs followed by
diabetes, which was found significant in three of the four
groups of modelling. Other conditions became significant
in different models. Some conditions are close to significant
using some methods and become significant using other
methods. In particular it is of interest that the two-part
joint modelling suggests asthma is a marginally (p = 0.049)
significant determinant of outlays, while this does not arise
for any of the other approaches. This may have arisen as
the combined effect of the probability of spending anyexpert suggested clinically relevant clusters
lly suggested clusters (not mutually exclusive)
l
1
Clinical
Cluster 2
Clinical
Cluster 3
Clinical
Cluster 4
Clinical
Cluster 5
Arthritis Heart Depression Cancer
itis Osteoporosis Stroke
HBP
Diabetes
Table 4 Summary of significantly high out-of-pocket expenditure in all models detailed in Tables 5, 6, 7 and 8
Model structure Zero vs some
OOPE: Table 5
Regression of log
of outlays: Table 6
Two-part joint: Table 7 Heavy vs normal
OOPE: Table 8
Total number of
conditions (Model 1)
Highly significant Highly significant Highly significant Highly significant
Individual Conditions
(Model 2)
Cancer, heart, HBP
and diabetes are
significant
Cancer, HBP, diabetes and
depression are significant
Cancer and asthma
are significant
Cancer and diabetes
are significant
Multiple morbidity
(Model 3)
Non-specific combinations
of two, three, four and more
conditions are significant
but not combinations of
particular conditions
Non-specific combinations
of three, four and more
conditions are significant
but not combinations of
particular conditions
Non-specific combinations
of conditions are significant
but not combinations of
particular conditions
Non-specific combinations
of two, three, four and
more conditions and the
combination of HBP, arthritis
and diabetes are significant
Natural clusters
(Model 4)
All clusters significant All clusters significant All clusters significant All clusters significant
Clinical clusters
(Model 5)
4 of 5 clusters are significant 4 of 5 clusters are significant Only cancer cluster is
significant
3 of 5 clusters are significant
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spending among those who reported any spending
(p = 0.06; Table 6), and the relatively high OOPE for
patients with asthma presented in Table 1 ($547).
As noted above, cancer stands out as the condition
which accounts for significantly higher OOPE than the
other chronic conditions. Comparison of clusters also
indicates that the cancer dominated cluster is the most
strongly associated with OOPE, and has the largest
impact on OOPE burden, although the differences are
not significant. This observation has substantial implications
for health care financing and management, as many
categories of cancers – once identified as lethal diseases –
now increasingly became manageable chronic diseases
due to earlier diagnosis and improved treatments.
Sub-analysis of our data shows that cancer patients
are more likely to report significantly more OOPE in
medical consultation and tests than other categories
of OOPE. This is consistent to the literature, as some
diagnostic tests and essential items such as MRI, PET
(a common cancer scan), bone density scans, wigs to
cover the balding head, special inner garments and
some cancer drugs are not covered by the Medicare
[39]. Also the gap payments for some tests, drugs and
services are another source of OOPE. A previous study
with cancer patients in rural Queensland also reported
substantial OOPE on medical consultations and tests
(14%) [10]. Together these findings warrant further
research as to how this OOPE can be reduced among
cancer patients.
Diabetes is also significantly associated with the overall
OOPE and high financial burden of healthcare costs,
and is a component of one of the clusters which is
significant in assessing financial burden. Patients with
diabetes reported significantly more OOPE than others in
two major categories: medications and equipment. This
is understandable given that a person with diabetesmay incur OOPE on a range of supplies and medica-
tions, such as syringes, lancets, glucose testing meters,
test strips, insulin pumps, insulin and/or other medi-
cations. Although all these supplies and medications
are highly subsidised and some are subject to a max-
imum annual payment cap, the gap amount for such
items on a regular basis may be substantial relative to
income. The ‘front loading’ structure in Australia,
where co-payments are made until the cap is reached,
after which prescriptions are further subsidised (for people
on higher incomes) or free (for people on lower incomes),
may lead to some patients deferring or avoiding having
prescriptions filled to avoid costs. Further, it must be
noted that non-prescription medicines are not subsidised,
and for many people these will represent a cost burden in
its own right.
One of the strengths of our study is its range of
approaches of disease groupings. Their associations
with the outcome variables, to some extent, depend
on the way they were grouped. For instance, natural
clusters were identified based on distance measure
(Yule’s Q); the specific groupings in ‘multiple morbidity’
and prevalent pairs were based on simple probability of
association and the clinical clusters were based on
‘concordant comorbidity’. Moreover, natural clusters
were mutually exclusive but the clinical clusters were
not. While the groupings of conditions in clusters or
in the most prevalent groups only assist in a minor
way in identifying those facing the greatest financial
burdens, these groupings may be of value for other
purposes. The knowledge of the structure of combinations
of chronic conditions may, for example, impact on matters
such as time use which we are exploring in further
research. Also future research should focus the evidence
base on which to formalise groupings which can be
more widely used to assist in our understanding of the
implications of different comorbidities.
Table 5 Logistic regression model exploring significant correlates of at least some OOPE (more than zero vs zero)
Variable Logistic model A1 Logistic model A2 Logistic model A3 Logistic model A4 Logistic model A5
OR p 95% CI OR p 95% CI OR p 95% CI OR p 95% CI OR p 95% CI
Number of chronic diseases 1.44 <0.01 1.33-1.57
Specific chronic conditions
Cancer 1.60 <0.01 1.23-2.08
Heart 1.54 <0.01 1.12-2.12
HBP 1.56 <0.01 1.29-1.89
Stroke 1.33 0.39 0.69-2.56
Diabetes 1.43 0.04 1.02-2.00
Asthma 1.26 0.09 0.96-1.65
Bronchitis 0.89 0.68 0.52-1.54
Arthritis 1.22 0.08 0.98-1.52
Osteoporosis 1.32 0.11 0.94-1.86
Depression 1.38 0.06 0.99-1.93
Multiple morbiditya
No disease 0.50 <0.01 0.36-0.69
Arthritis only 0.81 0.38 0.51-1.29
All others with one disease 1.01 0.97 0.71-1.44
HBP and arthritis 1.70 0.08 0.94-3.07
HBP and diabetes 1.07 0.85 0.53-2.16
HBP and heart disease 1.64 0.32 0.61-4.40
Arthritis and asthma 1.00 0.99 0.45-2.26
All others with two diseases 1.71 <0.01 1.19-2.47
HBP, arthritis and cancer 1.67 0.36 0.55-5.01
HBP, arthritis and diabetes 3.50 0.09 0.8-15.22
All others with three diseases 1.82 <0.01 1.22-2.71
All with four diseases 2.10 <0.01 1.29-3.41
All with more than four diseases 2.32 <0.01 1.29-4.15
Natural clusters
People with none of these conditions 1.00 - -
Group 1 (asthma-bronchitis-arthritis-osteoporosis-depression) 2.03 <0.01 1.56-2.65
Group 2 (HBP-Diabetes) 2.23 <0.01 1.74-2.86
Group 3 (heart-stroke) 2.93 <0.01 2.04-4.20
Group 4 (cancer) 2.40 <0.01 1.76-3.27
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Table 5 Logistic regression model exploring significant correlates of at least some OOPE (more than zero vs zero) (Continued)
Clinically suggested clusters
Asthma and bronchitis 1.19 0.18 0.92-1.54
Arthritis and osteoporosis 1.33 <0.01 1.07-1.64
Depression 1.39 0.05 0.99-1.93
Heart, HBP, stroke and diabetes 1.87 <0.01 1.54-2.26
Cancer 1.61 <0.01 1.24-2.10
Number of other chronic diseases 1.74 <0.01 1.42-2.14 1.71 <0.01 1.40-2.10 1.74 <0.01 1.42-2.13
Age groups
75+ 1.00 - - 1.00 - - 1.00 - - 1.00 - - 1.00 - -
50-64 years 1.03 0.82 0.79-1.36 1.04 0.76 0.79-1.38 1.09 0.56 0.82-1.43 1.05 0.74 0.80-1.38 1.05 0.74 0.79-1.38
65-74 years 1.00 0.97 0.80-1.27 1.00 0.97 0.79-1.27 1.03 0.82 0.81-1.30 1.02 0.84 0.81-1.30 1.00 0.99 0.79-1.26
Male 1.46 <0.01 1.21-1.76 1.40 <0.01 1.15-1.70 1.43 <0.01 1.18-1.73 1.37 <0.01 1.13-1.66 1.40 <0.01 1.15-1.69
SF-12 physical health score 0.95 <0.01 0.93-0.96 0.95 <0.01 0.93-0.96 0.95 <0.01 0.93-0.96 0.94 <0.01 0.92-0.95 0.95 <0.01 0.93-0.96
SF-12 mental health score 0.97 <0.01 0.95-0.99 0.97 <0.01 0.95-0.98 0.97 <0.01 0.95-0.98 0.96 <0.01 0.94-0.98 0.96 <0.01 0.95-0.98
Income
<20 000 (ref) 1.33 0.03 1.03-1.72 1.33 0.03 1.03-1.72 1.32 0.03 1.02-1.71 1.33 0.03 1.03-1.72 1.32 0.03 1.03-1.70
20000-40000 1.64 <0.01 1.23-2.18 1.63 <0.01 1.22-2.17 1.63 <0.01 1.22-2.18 1.64 <0.01 1.23-2.19 1.63 <0.01 1.22-2.18
40000-60000 2.00 <0.01 1.39-2.86 1.97 <0.01 1.37-2.83 1.97 <0.01 1.37-2.83 1.93 <0.01 1.35-2.77 1.95 <0.01 1.36-2.80
60000-80000 2.72 <0.01 1.74-4.26 2.70 <0.01 1.72-4.24 2.79 <0.01 1.77-4.40 2.79 <0.01 1.77-4.39 2.77 <0.01 1.76-4.34
80000-100000 2.27 <0.01 1.54-3.36 2.23 <0.01 1.51-3.30 2.22 <0.01 1.50-3.29 2.23 <0.01 1.50-3.30 2.24 <0.01 1.51-3.32
Region
Remote 1.00 - - 1.00 - - 1.00 - - 1.00 - - 1.00 - -
Cities 2.06 0.02 1.13-3.74 2.07 0.02 1.14-3.77 2.23 <0.01 1.22-4.08 2.16 0.01 1.19-3.93 2.14 0.01 1.18-3.90
Regional 2.09 0.02 1.14-3.81 2.10 0.02 1.15-3.83 2.24 <0.01 1.22-4.10 2.16 0.01 1.18-3.95 2.15 0.01 1.18-3.93
n = 3635; Pseudo
R2 = 0.09
n = 3635; Pseudo
R2 = 0.10
n = 3635; Pseudo
R2 = 0.10
n = 3635; Pseudo
R2 = 0.10
n = 3635; Pseudo
R2 = 0.10
AIC = 3072; BIC = 3159 AIC = 3080; BIC = 3229 AIC = 3073; BIC = 3234 AIC = 3072; BIC = 3184 AIC = 3065; BIC = 3183
aReference group is the participants with only HBP.
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Table 6 Linear regression models reflecting correlates of out-of-pocket expenditure among participants who reported some expenditure
Variable Linear model 1 Linear model 2 Linear model 3 Linear model 4 Linear model 5
Β** P 95% CI Β** p 95% CI Β** p 95% CI Β** p 95% CI Β** p 95% CI
Number of chronic diseases 1.20 <0.01 1.14-1.26
Specific chronic conditions
Cancer 1.27 <0.01 1.09-1.48
Heart 1.19 0.06 0.99-1.42
HBP 1.14 0.04 1.00-1.29
Stroke 1.09 0.64 0.76-1.55
Diabetes 1.25 0.03 1.02-1.52
Asthma 1.18 0.06 0.99-1.40
Bronchitis 1.33 0.09 0.95-1.87
Arthritis 1.12 0.12 0.97-1.29
Osteoporosis 1.19 0.13 0.95-1.48
Depression 1.26 0.01 1.05-1.52
Multiple morbiditya
No disease 0.92 0.55 0.70-1.21
Arthritis only 0.98 0.90 0.66-1.44
All others with one disease 1.21 0.16 0.93-1.59
HBP and arthritis 1.32 0.16 0.90-1.94
HBP and diabetes 1.21 0.47 0.72-2.03
HBP and heart disease 0.72 0.29 0.40-1.31
Arthritis and asthma 0.82 0.57 0.42-1.61
All others with two diseases only 1.27 0.06 0.99-1.64
HBP, arthritis and cancer 1.63 0.14 0.85-3.12
HBP, arthritis and diabetes 1.79 0.09 0.91-3.50
All others with three diseases only 1.51 <0.01 1.15-1.97
All with four diseases only 1.92 <0.01 1.42-2.60
All with more than four diseases 2.46 <0.01 1.77-3.41
Natural clusters
People with none of these conditions 1.00 - -
Group 1 (asthma-bronchitis-arthritis-osteoporosis-depression) 1.34 <0.01 1.08-1.66
Group 2 (HBP-Diabetes) 1.22 0.05 1.01-1.49
Group 3 (heart-stroke) 1.42 <0.01 1.11-1.81
Group 4 (cancer) 1.52 <0.01 1.21-1.91
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Table 6 Linear regression models reflecting correlates of out-of-pocket expenditure among participants who reported some expenditure (Continued)
Clinically suggested clusters
Asthma and bronchitis 1.21 0.02 1.03-1.42
Arthritis and osteoporosis 1.12 0.12 0.97-1.29
Depression 1.27 0.01 1.06-1.53
Heart, HBP, stroke and diabetes 1.22 <0.01 1.07-1.38
Cancer 1.28 <0.01 1.09-1.49
Number of other chronic diseases 1.23 <0.01 1.11-1.36 1.21 <0.01 1.09-1.34 1.22 <0.01 1.11-1.35
Age groups
75+ 1.00 - - 1.00 - - 1.00 - - 1.00 - - 1.00 - -
50-64 years 1.38 <0.01 1.15-1.66 1.36 <0.01 1.12-1.65 1.37 <0.01 1.13-1.65 1.37 <0.01 1.13-1.66 1.33 <0.01 1.10-1.61
65-74 years 1.15 0.09 0.98-1.35 1.14 0.11 0.97-1.35 1.14 0.11 0.97-1.34 1.15 0.09 0.97-1.36 1.13 0.15 0.96-1.33
Male 1.34 <0.01 1.18-1.52 1.32 <0.01 1.16-1.51 1.33 <0.01 1.17-1.51 1.30 <0.01 1.14-1.48 1.33 <0.01 1.16-1.52
SF-12 physical health score 0.97 <0.01 0.97-0.98 0.97 <0.01 0.96-0.98 0.97 <0.01 0.97-0.99 0.97 <0.01 0.96-0.98 0.97 <0.01 0.96-0.98
SF-12 mental health score 0.98 <0.01 0.97-0.99 0.98 0.01 0.97-0.99 0.98 <0.01 0.97-0.99 0.98 <0.01 0.97-0.99 0.98 0.01 0.97-1.00
Income
<20 000 (ref) 1.00 - - 1.00 - - 1.00 - - 1.00 - - 1.00 - -
20000-40000 1.09 0.40 0.89-1.32 1.10 0.38 0.90-1.33 1.10 0.39 0.89-1.33 1.10 0.34 0.90-1.34 1.09 0.40 0.89-1.33
40000-60000 1.46 <0.01 1.18-1.81 1.46 <0.01 1.18-1.81 1.48 <0.01 1.20-1.84 1.47 <0.01 1.19-1.83 1.46 <0.01 1.18-1.81
60000-80000 1.74 <0.01 1.35-2.24 1.74 <0.01 1.35-2.25 1.74 <0.01 1.34-2.25 1.72 <0.01 1.33-2.31 1.73 <0.01 1.34-2.24
80000-100000 1.79 <0.01 1.34-2.40 1.78 <0.01 1.33-2.39 1.77 <0.01 1.32-2.37 1.77 <0.01 1.31-2.37 1.77 <0.01 1.32-2.37
>100 000 2.21 <0.01 1.69-2.88 2.20 <0.01 1.68-2.88 2.19 <0.01 1.67-2.86 2.16 <0.01 1.65-2.83 2.18 <0.01 1.67-2.85
Region
Remote 1.00 - - 1.00 - - 1.00 - - 1.00 - - 1.00 - -
Cities 1.65 0.05 1.00-2.72 1.64 0.05 0.99-2.71 1.68 0.04 1.02-2.78 1.67 0.04 1.01-2.77 1.65 0.05 1.00-2.72
Regional 1.36 0.23 0.82-2.24 1.34 0.25 0.81-2.23 1.37 0.22 0.83-2.27 1.36 0.23 0.82-2.26 1.34 0.25 0.81-2.22
n = 1595; R2 = 0.14 n = 1595; R2 = 0.14 n = 1595; R2 = 0.14 n = 1595; R2 = 0.13 n = 1595; R2 = 0.14
AIC = 5247; BIC = 5322 AIC = 5263; BIC = 5392 AIC = 5260; BIC = 5400 AIC = 5279; BIC = 5376 AIC = 5262; BIC = 5365
aReference group is the participants with only HBP; ** Exponentiated values of the coefficients estimated in the linear model of the logarithm of the OOPE.
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Table 7 Two part joint regression models reflecting marginal effects of associated variables on out of pocket expenditure
Variable TPM model 1 TPM model 2 TPM model 3 TPM model 4 TPM model 5
dy/dx p 95% CI dy/dx p 95% CI dy/dx p 95% CI dy/dx p 95% CI dy/dx p 95% CI
Number of chronic diseases 89.1 ** 53.4, 124.9
Specific chronic conditions
Cancer 257.7 ** 151.2, 364.1
Heart 70.3 -44.1, 184.7
HBP 28.5 -51.8, 108.7
Stroke 0.5 -229.3, 230.3
Diabetes 84.4 -41.7, 210.6
Asthma 112.1 * 0.7, 223.5
Bronchitis 4.6 -213, 222.2
Arthritis 0.6 -90.8, 92.1
Osteoporosis 43.2 -97.8, 184.2
Depression 75.5 -47.2, 198.1
Multiple morbiditya
No disease -95.2 -206.6, 16.3
Arthritis only -40.6 -203.9, 122.8
All others with one disease 198.6 * 38.7, 358.5
HBP and arthritis 41.3 -148.5, 231.0
HBP and diabetes 9.7 -232.3, 251.7
HBP and heart disease -100.1 -294.7, 94.4
Arthritis and asthma -154.9 -328.7, 18.9
All others with two diseases only 169.6 * 31.6, 307.6
HBP, arthritis and cancer 63.0 -285.3, 411.3
HBP, arthritis and diabetes 233.3 -273.8, 740.4
All others with three diseases only 151.3 * 6.4, 296.1
All with four diseases only 251.5 * 55.1, 447.9
All with more than four diseases 552.0 ** 241.3, 862.7
Natural clusters
People with none of these conditions 1.00 -
Group 1 (asthma-bronchitis-arthritis-osteoporosis-depression) 139.3 * 33.0, 245.5
Group 2 (HBP-Diabetes) 123.4 * 27.2, 219.5
Group 3 (heart-stroke) 187.9 ** 52.8, 322.9
Group 4 (cancer) 377.5 ** 215.9, 539.0
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Table 7 Two part joint regression models reflecting marginal effects of associated variables on out of pocket expenditure (Continued)
Clinically suggested clusters
Asthma and bronchitis 97.6 -7.1, 202.3
Arthritis and osteoporosis -3.1 -92.0, 85.9
Depression 77.6 -44.2, 199.5
Heart, HBP, stroke and diabetes 63.3 -17.5, 144.1
Cancer 255.0 ** 150.2, 359.8
Number of other chronic disease 146.9 ** 83.1, 210.6 147.9 ** 84.2, 211.6 146.8 ** 83.5, 210.1
Age groups
75+ 1.00 - - 1.00 - 1.00 - - 1.00 - 1.00 -
50-64 years 115.9 -7.18, 238.9 78.6 -37.8, 195.0 112.4 * 0.1, 224.8 82.5 -30.5, 195.6 69.6 -43.5, 182.7
65-74 years 92.9 -8.11, 193.9 72.9 -22.8, 168.6 91.3 -2.0, 184.6 71.1 -23.6, 165.7 66.4 -28.5, 161.3
Male 141.1 ** 46.2, 236.1 128.9 ** 40.7, 217.0 145.0 ** 58.5, 231.4 123.1 ** 37.2, 209.0 127.5 ** 41.0, 214.1
SF-12 physical health score -11.9 ** -19.1, -4.8 -12.0 ** -18.5, -5.5 -12.4 ** -19.0, -5.9 -12.6 ** -19.0, -6.3 -12.4 ** -18.8, -5.9
SF-12 mental health score -12.2 ** -20.4, -4.1 -11.8 ** -19.6, -4.1 -11.9 ** -19.3, -4.6 -14.3 ** -21.6, -7.0 -12.2 ** -19.9, -4.6
Income
<20 000 (ref) 1.00 - - 1.00 - - 1.00 - - 1.00 1.00 - -
20000-40000 -22.7 -130.8, 85.4 1.5 -92.7, 95.7 -6.1 -102.5, 90.3 5.7 -86.6, 98.1 1.6 -91.7, 94.9
40000-60000 126.7 -11.5, 264.9 150.6 * 27.6, 273.7 146.0 * 21.4, 270.6 154.3 * 34.6, 273.9 152.4 * 31.2, 273.6
60000-80000 239.8 * 41.7, 437.9 265.4 ** 86.8, 444.0 267.4 * 82.7, 452.1 255.6 ** 82.2, 429.0 268.9 ** 91.0, 446.8
80000-100000 272.3 * 23.0, 521.6 256.7 * 44.1, 469.2 290.4 * 62.9, 517.8 307.4 ** 81.5, 533.3 264.8 * 53.1, 476.5
>100 000 397.4 ** 140.7, 654.1 397.0 ** 174.1, 619.9 363.2 ** 145.7, 580.7 398.4 ** 177.7, 619.1 401.7 ** 178.8, 624.6
Region
Remote 1.00 - - 1.00 - 1.00 1.00 1.00 -
Cities 213.7 * 3.5, 423.9 228.3 * 47.1, 409.4 246.5 * 71.0, 422.0 225.2 * 46.0, 404.3 232.1 * 55.5, 408.7
Regional 164.7 -45.7, 375.2 178.2 -3.8, 360.2 179.7 * 5.1, 354.3 183.3 * 2.8, 363.8 182.0 * 4.7, 359.3
n = 2226 n = 2226 n = 2226 n = 2226 n = 2226
AIC = 25827; BIC = 25987 AIC = 25782; BIC = 26056 AIC = 25777; BIC = 26074 AIC = 25784; BIC = 25989 AIC = 25761; BIC = 25978
** < 0.01, * < 0.05; aReference group is the participants with only HBP.
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Table 8 Logistic regression model exploring significant correlates for respondents spending over 10% of income on health
Variable Logistic model B1 Logistic model B2 Logistic model B3 Logistic model B4 Logistic model B5
OR p 95% CI OR p 95% CI OR p 95% CI OR p 95% CI OR p 95% CI
Number of chronic diseases 1.36 <0.01 1.24-1.49
Specific chronic conditions
Cancer 1.38 0.04 1.02-1.87
Heart 1.27 0.17 0.91-1.79
HBP 1.09 0.50 0.84-1.42
Stroke 0.95 0.88 0.47-1.91
Diabetes 1.79 <0.01 1.25-2.57
Asthma 1.32 0.10 0.95-1.85
Bronchitis 1.59 0.11 0.90-2.81
Arthritis 1.19 0.23 0.90-1.58
Osteoporosis 1.13 0.58 0.73-1.77
Depression 1.33 0.12 0.93-1.89
Multiple morbiditya
No disease 0.81 0.54 0.41-1.60
Arthritis only 1.40 0.43 0.60-3.28
All others with one disease 1.51 0.21 0.79-2.87
HBP and arthritis 1.51 0.37 0.62-3.67
HBP and diabetes 2.31 0.10 0.86-6.17
HBP and heart disease 0.41 0.40 0.05-3.27
Arthritis and asthma b b b
All others with two diseases 1.87 0.04 1.02-3.42
HBP, arthritis and cancer 1.11 0.90 0.23-5.33
HBP, arthritis and diabetes 4.98 0.01 1.51-16.41
All others with three diseases 1.87 0.05 1.00-3.51
All with four diseases 2.71 <0.01 1.40-5.23
All with more than four diseases 5.08 <0.01 2.61-9.90
Natural clusters
People with none of these conditions 1.00 - -
Group 1 (asthma-bronchitis-arthritis-osteoporosis-depression) 1.59 0.05 1.01-2.53
Group 2 (HBP-Diabetes) 1.66 0.02 1.07-2.58
Group 3 (heart-stroke) 1.74 0.03 1.05-2.88
Group 4 (cancer) 1.82 0.02 1.12-2.94
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Table 8 Logistic regression model exploring significant correlates for respondents spending over 10% of income on health (Continued)
Clinically suggested clusters
Asthma and bronchitis 1.41 0.03 1.03-1.92
Arthritis and osteoporosis 1.16 0.29 0.88-1.54
Depression 1.33 0.12 0.93-1.89
Heart, HBP, stroke and diabetes 1.33 0.04 1.02-1.73
Cancer 1.37 0.04 1.02-1.86
Number of other chronic diseases 1.65 <0.01 1.38-1.98 1.60 <0.01 1.34-1.92 1.73 0.00 1.33-2.26
Age groups
75+ 1.00 - - 1.00 - - 1.00 - - 1.00 - - 1.00 - -
50-64 years 1.07 0.71 0.74-1.54 0.97 0.86 0.66-1.42 1.04 0.83 0.72-1.51 0.98 0.90 0.67-1.41 0.96 0.84 0.66-1.40
65-74 years 1.29 0.11 0.94-1.78 1.23 0.22 0.89-1.70 1.31 0.10 0.95-1.80 1.23 0.20 0.89-1.69 1.22 0.23 0.88-1.67
Male 1.77 <0.01 1.36-2.29 1.70 <0.01 1.29-2.23 1.71 <0.01 1.32-2.22 1.65 <0.01 1.27-2.15 1.73 <0.01 1.33-2.26
SF-12 physical health score 0.97 <0.01 0.95-0.99 0.97 <0.01 0.95-0.99 0.97 <0.01 0.95-0.99 0.96 <0.01 0.94-0.98 0.97 <0.01 0.95-0.98
SF-12 mental health score 0.97 0.01 0.95-0.99 0.97 0.01 0.95-0.99 0.97 0.01 0.95-0.99 0.96 <0.01 0.94-0.99 0.97 0.01 0.95-0.99
Region
Remote 1.00 - - 1.00 - - 1.00 - - 1.00 - - 1.00 - -
Cities 2.87 0.09 0.84-9.82 2.92 0.09 0.84-10.19 3.00 0.08 0.87-10.39 2.80 0.10 0.82-9.49 2.79 0.10 0.82-9.51
Regional 2.68 0.12 0.78-9.19 2.75 0.11 0.78-9.62 2.75 0.11 0.79-9.56 2.58 0.13 0.76-8.81 2.58 0.13 0.75-8.85
n = 2227; Pseudo
R2 = 0.08
n = 2227; Pseudo
R2 = 0.09
n = 2203; Pseudo
R2 = 0.08
n = 2227; Pseudo
R2 = 0.07
n = 2227; Pseudo
R2 = 0.08
AIC = 1657; BIC = 1709 AIC = 1665; BIC = 1773 AIC = 1662; BIC = 1776 AIC = 1674; BIC = 1748 AIC = 1665; BIC = 1745
aReference group is the participants with only HBP; b: Not calculated due to zero cell value.
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http://www.biomedcentral.com/1471-2458/14/1008Levels of OOPE in Australia are high by high-income
country standards [40,41]. International comparison of
adults with chronic conditions from eleven OECD countries
in 2011 found that around one third of Australians avoided
some component of care due to cost issues in the past year.
This was a higher proportion than citizens of any other
member country, except the USA [40]. A previous study
showed that people with multimorbidity are likely to have
relatively low income, and demonstrated the impact of
chronic conditions on the proportion of equivalised income
expended on health is more extreme than the impact on
the level of expenditure. Thus cost burden falls most heavily
on those with multiple chronic conditions [42] and those
least able to bear it [43] – a group who are vulnerable
both in terms of health and income. It is clear that senior
Australians, even with the protection of Medicare, may
face a burden of substantial OOPE.
One of the main findings of our study is that male
patients with multiple chronic conditions, particularly
cancer or diabetes, who had poor physical and mental
health as reflected in the SF-12, had relatively high
income, and lived in city areas are more likely to report
higher OOPE. While our data are limited and do not
explain the reasons for this observation, the possible
explanation of this is likely to be multifaceted. Firstly, it is
understandable, as our results suggest, that people with
multiple chronic conditions and more severe diseases
particularly cancer or diabetes are likely to incur more
OOPE. Secondly, participants with relatively high income
level have a tendency to enjoy better care and to be ready
to pay more. For instance, they are likely to prefer to see
specialist doctors in private practice, with relatively high
consulting fees, than to ‘wait their turn’ in the public
system. Although there is a provision of rebate through
the Medicare scheme, the gap amount is borne by the
patient and/or the private health insurance. Thirdly, high
income patients do not enjoy all the concessions that the
low-income patients do. Fourthly, available health care
facilities in the city areas, unlike remote areas where there
are limited opportunities, may influence the OOPE.
Although for many services costs are higher in rural areas,
overall expenditure is determined by the volume of
services which is lower in rural areas. Finally, as males on
average die significantly earlier than females in Australia
and all patients face higher costs in their last years of life,
this may impact on the higher costs observed for males
than females.
Although people with relatively high income pay
more OOPE than people with relatively low income,
low income patients are more likely to face a heavy
financial burden related to OOPE. Findings therefore
suggest that despite a healthcare system that provides
universal coverage and a well-established and extensive
system of social security, some individuals with chronicillness face substantial cost burden, which falls most heav-
ily on those least able to bear it. As household economic
burden is skewed toward specific patient groups; effective
remedies could include focused interventions such as
income support and subsidies [11]. Our observation,
for example that, male patients with multiple chronic
conditions particularly cancer or diabetes and who
had poor physical and mental health are likely to face
a heavy burden of OOPE (Table 8) could point to
one sub-group for targeted intervention. While such
fine targeting may not be practicable, further research
on the effects of burdensome costs would be helpful
in refining supportive policies. Previous studies in
Australia have shown that people defer or avoid filling
prescriptions because of cost [44], although it is unknown
whether they avoid both prescription and non-prescription
drugs, and what choices they make in this regard.
Limitations
We used a cross-sectional design to recruit participants and
thus are unable to assess change in financial circumstances
over time, or to understand the degree to which financial
burdens trend upwards or downwards with changing health
conditions. The expenditure data is based on recall,
and perhaps more importantly the relatively short
recall period needed to minimise recall error which
will lead to high variability for conditions that have
less frequent but expensive events. The response rate
of 45.7% is highly acceptable for a mail survey in the
Australian context, and leads to a reasonably large
sample of 4,570 respondents. However, in combination
with the structure of the National Seniors Australia
membership this response rate leads to a risk that the
sample may not perfectly represent the wider population
of older Australians. Our sample is better educated than
the wider Australian populations of same age, although
their health conditions broadly reflect those of the wider
population. Testing suggests that any biases from
these effects are minimal, particularly as we are exploring
relationships rather than estimated prevalences or dollar
amounts. Our sample had only 15 participants who
identified themselves as indigenous which is significantly
less than the proportion of the population in this age
range. We believe this is principally due to the relatively
low proportion of Indigenous Australians who are
members of the National Seniors Australia organisation,
and hence the relatively small numbers in our sample
frame. The OOPE and its corresponding effects will be
different in a health care system in another country that
has a different costs base. For example, in Australia a
safety net based on income and total annual expenditure
applies. Thus our findings may not be generalizable
to other settings, and all aspects of OOPE may not be
applicable for other chronic conditions. But the models
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to identify where policy interventions can be most
protective.
Conclusion
The ability to identify patients who incur excessive
OOPE is useful for appropriate policy formulation. OOPE is
common among senior Australians with chronic conditions
and this expenditure increases with number of chronic con-
ditions. The poor pay a higher proportion of their income
as OOPE than the well-off. Among the individual condi-
tions, the OOPE is significantly higher for patients with can-
cer than patients with any other condition. HBP, diabetes,
depression are also important conditions in terms of rela-
tively high OOPE. Patients with cancer or diabetes are more
likely to spend over 10% of their household income on
health related purchases. With the set of conditions tested
in this study, disease clusters do not provide a means to esti-
mate OOPE. As the burden of healthcare costs on individ-
uals is likely to continue to increase, policies are needed
targeting patients with the most conditions, with cancers,
and those on low incomes as they are most likely to face
severe financial burdens due to their healthcare.
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